Public perception and community-level impact of national action plans on antimicrobial resistance in Vietnam.


Journal

JAC-antimicrobial resistance
ISSN: 2632-1823
Titre abrégé: JAC Antimicrob Resist
Pays: England
ID NLM: 101765283

Informations de publication

Date de publication:
Feb 2024
Historique:
received: 06 02 2023
accepted: 05 12 2023
medline: 2 1 2024
pubmed: 2 1 2024
entrez: 1 1 2024
Statut: epublish

Résumé

Vietnam was the first country from the WHO Western Pacific Region to adopt a national action plan (NAP) on antimicrobial resistance (AMR) in 2013. The multilayered nature of AMR requires coordination across 'One Health' sectors, dedicated financing, multistakeholder involvement, and widespread community engagement to implement the action plans. This study explores the perceived impact of NAP implementation at the community level. Key informant interviews (KIIs) were used for data collection during 2021. An interview tool was used for the KIIs and purposive sampling was used to identify study participants from Vietnam. The study participants were those engaged with a substantial scale of antimicrobial usage, diagnosis of infections or concerned with antimicrobial content in effluents in their professional life. Twelve KIIs were conducted with participants from human health, animal health and the environmental sector. The data were entered into Microsoft Excel, and manifest and latent content analysis was done. The analysis highlighted themes such as limited public awareness of AMR, ongoing capacity building and quality assurance initiatives, implementation of guidelines and regulations for AMR containment, sustained investment in improving infrastructure, and challenges relating to accountability whilst prescribing and selling antibiotics. There were many positive critical developments during the NAP implementation period in Vietnam towards AMR mitigation. For better impact, there is a need to revitalize the implementation machinery of NAPs by improving the enforcement capacity of regulations, cross-sectoral collaboration and promoting community ownership.

Identifiants

pubmed: 38161968
doi: 10.1093/jacamr/dlad146
pii: dlad146
pmc: PMC10753920
doi:

Types de publication

Journal Article

Langues

eng

Pagination

dlad146

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.

Auteurs

Shruthi Anna Thomas (SA)

ReAct Asia Pacific, Christian Medical College, Vellore, Tamil Nadu, India.

Philip Mathew (P)

ReAct Asia Pacific, Christian Medical College, Vellore, Tamil Nadu, India.

Jaya Ranjalkar (J)

ReAct Asia Pacific, Christian Medical College, Vellore, Tamil Nadu, India.

Thi Bich Van Nguyen (TBV)

Ausvet Representative Office, Ho Chi Minh City, Vietnam.

Vu Thi Quynh Giao (VTQ)

Oxford University Clinical Research Unit, Hanoi, Vietnam.

Sujith J Chandy (SJ)

Department of Pharmacology & Clinical Pharmacology, Christian Medical College, Vellore, Tamil Nadu, India.

Classifications MeSH